C G M Kallenberg Selected Research

C G M Kallenberg Research Topics

Disease

18	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017 - 07/2002
14	Vasculitis (Vasculitides) 06/2015 - 07/2002
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2013 - 01/2002
12	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 06/2002
10	Inflammation (Inflammations) 05/2013 - 05/2008
6	Microscopic Polyangiitis 01/2017 - 09/2004
5	Autoimmune Diseases (Autoimmune Disease) 01/2014 - 05/2002
4	Systemic Vasculitis 10/2012 - 09/2004
3	Infections 01/2017 - 01/2011
3	Ankylosing Spondylitis 05/2011 - 09/2010
3	Systemic Scleroderma (Systemic Sclerosis) 01/2011 - 10/2007
3	Rheumatoid Arthritis 12/2010 - 05/2009
3	Necrosis 08/2010 - 11/2006
2	Glomerulonephritis 11/2014 - 01/2009
2	Atherosclerosis 10/2012 - 05/2008
2	Lupus Nephritis 08/2012 - 01/2002
2	Communicable Diseases (Infectious Diseases) 03/2011 - 01/2011
2	Sjogren's Syndrome (Sjogren Syndrome) 02/2009 - 06/2005
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2009 - 02/2008
1	Disease Progression 06/2015
1	Nephritis 11/2014
1	Proteinuria 11/2014
1	Ischemia 10/2012
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2012
1	Vascular Diseases (Vascular Disease) 10/2012
1	Stroke (Strokes) 10/2012
1	Acute Coronary Syndrome 10/2012
1	Atherosclerotic Plaque (Atheroma) 10/2012
1	Immune System Diseases (Immune Disorders) 08/2012
1	Bone Resorption 05/2011
1	Osteoporosis 05/2011
1	Metabolic Bone Diseases (Osteopenia) 05/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2010
1	Sarcoidosis (Schaumann Disease) 12/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2010
1	Serum Sickness 04/2010
1	Fatigue 04/2010
1	Acute Kidney Injury (Acute Renal Failure) 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2009

Drug/Important Bio-Agent (IBA)

20	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 06/2002
9	AntibodiesIBA 01/2017 - 01/2002
9	Rituximab (Mabthera)FDA Link 06/2015 - 06/2005
9	AutoantibodiesIBA 01/2014 - 01/2002
7	Myeloblastin (Proteinase 3)IBA 01/2017 - 06/2002
4	HMGB1 Protein (HMG1)IBA 11/2014 - 08/2010
4	Peroxidase (Myeloperoxidase)IBA 01/2009 - 07/2002
3	Peptide Hydrolases (Proteases)FDA Link 06/2015 - 11/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013 - 01/2004
3	Azathioprine (Imuran)FDA LinkGeneric 09/2013 - 06/2006
3	VaccinesIBA 04/2011 - 01/2011
2	Prednisone (Sone)FDA LinkGeneric 06/2015 - 09/2013
2	Advanced Glycation End ProductsIBA 08/2012 - 01/2011
2	Receptor for Advanced Glycation End ProductsIBA 08/2012 - 08/2010
2	C-Reactive ProteinIBA 05/2011 - 07/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 08/2010
2	CytokinesIBA 12/2010 - 07/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2006 - 01/2004
2	anti-dsDNA autoantibodyIBA 01/2006 - 01/2002
2	Immunoglobulin G (IgG)IBA 01/2004 - 01/2002
2	AutoantigensIBA 07/2002 - 06/2002
1	Immunoglobulin M (IgM)IBA 01/2017
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	GlucocorticoidsIBA 06/2015
1	CreatinineIBA 11/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2014
1	Biological ProductsIBA 01/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2012
1	25-hydroxyvitamin DIBA 05/2011
1	Peptides (Polypeptides)IBA 05/2011
1	Collagen Type I (Type I Collagen)IBA 05/2011
1	ProcollagenIBA 05/2011
1	OsteocalcinIBA 05/2011
1	Biomarkers (Surrogate Marker)IBA 05/2011
1	Vitamin D FDA LinkGeneric 05/2011
1	Immunomodulating AgentsIBA 04/2011
1	Monoclonal AntibodiesIBA 12/2010
1	RadiopharmaceuticalsIBA 12/2010
1	Histones (Histone)IBA 08/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2010
1	ChromatinIBA 08/2010
1	LipopolysaccharidesIBA 08/2010
1	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2010
1	Rheumatoid FactorIBA 04/2010
1	SodiumIBA 11/2009
1	Transcription Factors (Transcription Factor)IBA 11/2009
1	Antinuclear AntibodiesIBA 06/2009
1	LigandsIBA 05/2009
1	Prostaglandins AIBA 01/2009
1	Methylprednisolone FDA LinkGeneric 01/2009
1	AntigensIBA 01/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2008
1	oxidized low density lipoproteinIBA 05/2008
1	Lipoprotein(a)IBA 05/2008

Therapy/Procedure

5	Therapeutics 09/2013 - 07/2006
2	Remission Induction 09/2013 - 06/2006
1	Retreatment 02/2009
1	Plasma Exchange 01/2009